Details of Drug

Drug General Information (ID: D0266)
Drug Name	Carteolol (ophthalmic)
Drug Type	Small molecule
Drug Synonymous	Carteololum; Carteolol HCl; Carteolol Monohydrochloride; Arteolol (TN); Arteoptic (TN); Calte (TN); Carteol (TN); Carteolol (INN); Carteolol [INN:BAN]; Carteololum [INN-Latin]; Cartrol (TN); Elebloc (TN); Endak (TN); Glauteolol (TN); Mikelan (TN); Ocupress (TN); Poenglaucol (TN); Singlauc (TN); Teoptic (TN); 5-({3-[(1,1-dimethylethyl)amino]-2-hydroxypropyl}oxy)-3,4-dihydroquinolin-2(1H)-one; 5-[3-(tert-butylamino)-2-hydroxypropoxy]-3,4-dihydro-1H-quinolin-2-one; 5-[3-(tert-butylamino)-2-hydroxypropoxy]-3,4-dihydroquinolin-2(1H)-one Click to Show/Hide
Disease Class	9C61: Glaucoma
Therapeutic Class	Antihypertensive Agents
Structure
Structure	3D Structure		2D Structure
Formula	C16H24N2O3
InChI	1S/C16H24N2O3/c1-16(2,3)17-9-11(19)10-21-14-6-4-5-13-12(14)7-8-15(20)18-13/h4-6,11,17,19H,7-10H2,1-3H3,(H,18,20)
InChIKey	LWAFSWPYPHEXKX-UHFFFAOYSA-N
Canonical SMILES	CC(C)(C)NCC(COC1=CC=CC2=C1CCC(=O)N2)O
External Link
	Pubchem ID	2583
	CAS Number	51781-06-7
	CHEBI ID	3437
	TTD ID	D03GCJ

Drug-Drug Interaction Network
Sunburst Graph		Legend Information AM003 Affected organization distribution AM004 Affected intra/extra-hepatic metabolism AM006 Pharmacodynamic additive effects AM007 Pharmacodynamic antagonistic effects BM014 Interference of cell/tissue uptake BM017 CYP450 enzyme inhibition BM036 Additive cardiorespiratory depression effects BM041 Additive hypertensive effects BM042 Additive hypotensive effects BM045 Additive neuromuscular blocking effects BM048 Increased risk of angioedema/anaphylactoid reactions BM049 Increased risk of atrioventricular block BM051 Increased risk of bradycardia BM052 Increased risk of cardiac depression BM057 Increased risk of hyperglycemia BM062 Increased risk of hypertriglyceridemia BM064 Increased risk of hypoglycemia BM076 Increased risk of prolong QT interval BM081 Increased risk of ventricular arrhythmias BM083 Potentiated the pharmacological effects (Unspecific) BM086 Antagonize the effect of antidiabetic agents BM089 Antagonize the effect of antihypertensive agents BM090 Antagonize the effect of bronchodilators BM101 Antagonize the effects of beta receptor blockers BM107 Attenuated pharmacological effects (Unspecific)
Relation Graph

Full list of drugs interacting with Carteolol (ophthalmic)
Affected organization distribution
	Interference of cell/tissue uptake					Drug Num: 1
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0829		Iobenguane (I-131)	C8H10IN3	60860	Major		Inter Info	[16]
Affected intra/extra-hepatic metabolism
Pharmacodynamic additive effects
	Additive cardiorespiratory depression effects					Drug Num: 12
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0122		Atracurium	C53H72N2O12+2	47319	Moderate		Inter Info	[43], [44], [45]
D0343		Cisatracurium	C53H72N2O12+2	62887	Moderate		Inter Info	[43], [44], [45]
D0522		Doxacurium	C56H78N2O16+2	60169	Moderate		Inter Info	[43], [44], [45]
D1047		Metocurine	C40H48N2O6+2	21233	Moderate		Inter Info	[43], [44], [45]
D1080		Mivacurium	C58H80N2O14+2	5281042	Moderate		Inter Info	[43], [44], [45]
D1219		Pancuronium	C35H60N2O4+2	441289	Moderate		Inter Info	[43], [44], [45]
D1295		Pipecuronium	C35H62N4O4+2	50192	Moderate		Inter Info	[43], [44], [45]
D1384		Rapacuronium	C37H61N2O4+	5311399	Moderate		Inter Info	[43], [44], [45]
D1420		Rocuronium	C32H53N2O4+	441290	Moderate		Inter Info	[43], [44], [45]
D1659		Tubocurarine	C37H41N2O6+	6000	Moderate		Inter Info	[43], [44], [45]
D1684		Vecuronium	C34H57N2O4+	39765	Moderate		Inter Info	[43], [44], [45]
D1510		Succinylcholine	C14H30N2O4+2	5314	Moderate		Inter Info	[43], [44], [45]
	Additive hypertensive effects					Drug Num: 7
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0212		Bromocriptine	C32H40BrN5O5	31101	Moderate		Inter Info	[47], [48], [49]
D0592		Ergometrine	C19H23N3O2	443884	Moderate		Inter Info	[47], [48], [49]
D0494		Dihydroergotamine	C33H37N5O5	10531	Moderate		Inter Info	[47], [48], [49]
D1037		Methylergometrine	C20H25N3O2	8226	Moderate		Inter Info	[47], [48], [49]
D1043		Methysergide	C21H27N3O2	9681	Moderate		Inter Info	[47], [48], [49]
D1276		Phenylephrine	C9H13NO2	6041	Moderate		Inter Info	[99], [100]
D1278		Phenylephrine (ophthalmic)	C9H13NO2	6041	Moderate		Inter Info	[99], [100]
	Additive hypotensive effects					Drug Num: 39
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0036		Alfuzosin	C19H27N5O4	2092	Moderate		Inter Info	[23], [24], [25]
D0117		Atenolol	C14H22N2O3	2249	Moderate		Inter Info	[29], [30]
D0173		Betaxolol	C18H29NO3	2369	Moderate		Inter Info	[29], [30]
D0205		Brimonidine (ophthalmic)	C11H10BrN5	2435	Moderate		Inter Info	[34], [35], [36]
D0206		Brimonidine (topical)	C11H10BrN5	2435	Moderate		Inter Info	[34], [35], [36]
D0010		Acebutolol	C18H28N2O4	1978	Moderate		Inter Info	[29], [30]
D0098		Apraclonidine	C9H10Cl2N4	2216	Moderate		Inter Info	[34], [35], [36]
D0188		Bisoprolol	C18H31NO4	2405	Moderate		Inter Info	[29], [30]
D0267		Carvedilol	C24H26N2O4	2585	Moderate		Inter Info	[29], [30]
D0524		Doxazosin	C23H25N5O5	3157	Moderate		Inter Info	[23], [24], [25]
D0644		Fenoldopam	C16H16ClNO3	3341	Moderate		Inter Info	[61]
D0744		Guanethidine	C10H22N4	3518	Moderate		Inter Info	[71], [72], [73]
D0745		Guanfacine	C9H9Cl2N3O	3519	Moderate		Inter Info	[74], [11], [75]
D0853		Isocarboxazid	C12H13N3O2	3759	Moderate		Inter Info	[71], [72], [73]
D0884		Labetalol	C19H24N2O3	3869	Moderate		Inter Info	[29], [30]
D0933		Linezolid	C16H20FN3O4	441401	Moderate		Inter Info	[71], [72], [73]
D1098		Nadolol	C17H27NO4	39147	Moderate		Inter Info	[29], [30]
D1114		Nebivolol	C22H25F2NO4	71301	Moderate		Inter Info	[29], [30]
D1244		Penbutolol	C18H29NO2	37464	Moderate		Inter Info	[29], [30]
D1263		Phenelzine	C8H12N2	3675	Moderate		Inter Info	[71], [72], [73]
D1267		Phenoxybenzamine	C18H22ClNO	4768	Moderate		Inter Info	[23], [24], [25]
D1293		Pindolol	C14H20N2O2	4828	Moderate		Inter Info	[29], [30]
D1345		Procarbazine	C12H19N3O	4915	Moderate		Inter Info	[71], [72], [73]
D1357		Propranolol	C16H21NO2	4946	Moderate		Inter Info	[29], [30]
D1385		Rasagiline	C12H13N	3052776	Moderate		Inter Info	[71], [72], [73]
D1437		Safinamide	C17H19FN2O2	131682	Moderate		Inter Info	[71], [72], [73]
D1455		Selegiline	C13H17N	26757	Moderate		Inter Info	[71], [72], [73]
D1466		Silodosin	C25H32F3N3O4	5312125	Moderate		Inter Info	[23], [24], [25]
D1512		Sufentanil	C22H30N2O2S	41693	Moderate		Inter Info	[87], [88], [89]
D1552		Terazosin	C19H25N5O4	5401	Moderate		Inter Info	[23], [24], [25]
D1620		Tranylcypromine	C9H11N	19493	Moderate		Inter Info	[71], [72], [73]
D0508		Disopyramide	C21H29N3O	3114	Moderate		Inter Info	[95], [96], [97]
D0602		Esmolol	C16H25NO4	59768	Moderate		Inter Info	[29], [30]
D0743		Guanadrel	C10H19N3O2	38521	Moderate		Inter Info	[71], [72], [73]
D1049		Metoprolol	C15H25NO3	4171	Moderate		Inter Info	[29], [30]
D1331		Prazosin	C19H21N5O4	4893	Moderate		Inter Info	[23], [24], [25]
D1393		Reserpine	C33H40N2O9	5770	Moderate		Inter Info	[71], [72], [73]
D1498		Sotalol	C12H20N2O3S	5253	Moderate		Inter Info	[29], [30]
D1585		Timolol	C13H24N4O3S	33624	Moderate		Inter Info	[29], [30]
	Increased risk of angioedema/anaphylactoid reactions					Drug Num: 12
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D1783		Ethiodized oil	NA	NA	Moderate		Inter Info	[58], [59], [60]
D1787		Fluorescein	C20H12O5	16850	Moderate		Inter Info	[67], [68], [69]
D1791		Gadobenic acid	C22H28GdN3O11	9852779	Moderate		Inter Info	[7], [8], [70]
D1792		Gadobutrol	C18H31GdN4O9	6102852	Moderate		Inter Info	[7], [8], [70]
D1794		Gadofosveset trisodium	C33H38GdN3Na3O14P	73049652	Moderate		Inter Info	[7], [8], [70]
D1795		Gadopentetic acid	C14H20GdN3O10	6857474	Moderate		Inter Info	[7], [8], [70]
D1796		Gadoteric acid	C16H25GdN4O8	158536	Moderate		Inter Info	[7], [8], [70]
D1797		Gadoteridol	C17H29GdN4O7	60714	Moderate		Inter Info	[7], [8], [70]
D1798		Gadoversetamide	C20H34GdN5O10	444013	Moderate		Inter Info	[7], [8], [70]
D1826		Iopanoic acid	C11H12I3NO2	3735	Moderate		Inter Info	[58], [59], [60]
D1915		Tyropanoic acid	C15H18I3NO3	5611	Moderate		Inter Info	[58], [59], [60]
D1793		Gadodiamide	C16H26GdN5O8	153921	Moderate		Inter Info	[7], [8], [70]
	Increased risk of atrioventricular block					Drug Num: 2
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D1288		Pilocarpine	C11H16N2O2	5910	Moderate		Inter Info	[86]
D1579		Ticagrelor	C23H28F2N6O4S	9871419	Minor		Inter Info	[8], [101]
	Increased risk of bradycardia					Drug Num: 19
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0302		Ceritinib	C28H36ClN5O3S	57379345	Major		Inter Info	[7], [8], [9]
D0363		Clonidine	C9H9Cl2N3	2803	Major		Inter Info	[10], [11], [12]
D1474		Siponimod	C29H35F3N2O3	44599207	Major		Inter Info	[7], [19]
D0031		Alectinib	C30H34N4O2	49806720	Moderate		Inter Info	[37], [38]
D0066		Amiodarone	C25H29I2NO3	2157	Moderate		Inter Info	[39], [40], [41]
D0204		Brigatinib	C29H39ClN7O2P	68165256	Moderate		Inter Info	[46]
D0393		Crizotinib	C21H22Cl2FN5O	11626560	Moderate		Inter Info	[8], [50], [51]
D0490		Digitoxin	C41H64O13	441207	Moderate		Inter Info	[52], [53], [54]
D0534		Dronedarone	C31H44N2O5S	208898	Moderate		Inter Info	[57]
D0661		Fingolimod	C19H33NO2	107970	Moderate		Inter Info	[62], [63]
D0868		Ivabradine	C27H36N2O5	132999	Moderate		Inter Info	[7], [79]
D0891		Lanreotide	C54H69N11O10S2	71349	Moderate		Inter Info	[80], [81]
D0897		Lasmiditan	C19H18F3N3O2	11610526	Moderate		Inter Info	[82]
D1211		Ozanimod	C23H24N4O3	52938427	Moderate		Inter Info	[83]
D1230		Pasireotide	C58H66N10O9	9941444	Moderate		Inter Info	[84], [7], [85]
D1598		Tocainide	C11H16N2O	38945	Moderate		Inter Info	[92], [93], [94]
D0491		Digoxin	C41H64O14	2724385	Moderate		Inter Info	[52], [53], [54]
D1061		Midodrine	C12H18N2O4	4195	Moderate		Inter Info	[98]
D1163		Octreotide	C49H66N10O10S2	448601	Moderate		Inter Info	[80], [81]
	Increased risk of cardiac depression					Drug Num: 12
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D1690		Verapamil	C27H38N2O4	2520	Major		Inter Info	[20], [21], [22]
D0497		Diltiazem	C22H26N2O4S	39186	Major		Inter Info	[20], [21], [22]
D0069		Amlodipine	C20H25ClN2O5	2162	Moderate		Inter Info	[26], [27], [28]
D0170		Bepridil	C24H34N2O	2351	Moderate		Inter Info	[26], [27], [28]
D0352		Clevidipine	C21H23Cl2NO6	153994	Moderate		Inter Info	[26], [27], [28]
D0640		Felodipine	C18H19Cl2NO4	3333	Moderate		Inter Info	[26], [27], [28]
D0664		Flecainide	C17H20F6N2O3	3356	Moderate		Inter Info	[64], [65], [66]
D0911		Levamlodipine	C20H25ClN2O5	9822750	Moderate		Inter Info	[26], [27], [28]
D1130		Nicardipine	C26H29N3O6	4474	Moderate		Inter Info	[26], [27], [28]
D0865		Isradipine	C19H21N3O5	3784	Moderate		Inter Info	[26], [27], [28]
D1138		Nimodipine	C21H26N2O7	4497	Moderate		Inter Info	[26], [27], [28]
D1141		Nisoldipine	C20H24N2O6	4499	Moderate		Inter Info	[26], [27], [28]
	Increased risk of hyperglycemia					Drug Num: 16
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0158		Bendroflumethiazide	C15H14F3N3O4S2	2315	Moderate		Inter Info	[31], [32], [33]
D0166		Benzthiazide	C15H14ClN3O4S3	2343	Moderate		Inter Info	[31], [32], [33]
D0217		Bumetanide	C17H20N2O5S	2471	Moderate		Inter Info	[31], [32], [33]
D0321		Chlorothiazide	C7H6ClN3O4S2	2720	Moderate		Inter Info	[31], [32], [33]
D0613		Etacrynic acid	C13H12Cl2O4	3278	Moderate		Inter Info	[31], [32], [33]
D0704		Furosemide	C12H11ClN2O5S	3440	Moderate		Inter Info	[31], [32], [33]
D0771		Hydrochlorothiazide	C7H8ClN3O4S2	3639	Moderate		Inter Info	[31], [32], [33]
D0775		Hydroflumethiazide	C8H8F3N3O4S2	3647	Moderate		Inter Info	[31], [32], [33]
D0798		Indapamide	C16H16ClN3O3S	3702	Moderate		Inter Info	[31], [32], [33]
D1048		Metolazone	C16H16ClN3O3S	4170	Moderate		Inter Info	[31], [32], [33]
D1311		Polythiazide	C11H13ClF3N3O4S3	4870	Moderate		Inter Info	[31], [32], [33]
D1633		Trichlormethiazide	C8H8Cl3N3O4S2	5560	Moderate		Inter Info	[31], [32], [33]
D0326		Chlorthalidone	C14H11ClN2O4S	2732	Moderate		Inter Info	[31], [32], [33]
D1501		Spironolactone	C24H32O4S	5833	Moderate		Inter Info	[31], [32], [33]
D1611		Torasemide	C16H20N4O3S	41781	Moderate		Inter Info	[31], [32], [33]
D1631		Triamterene	C12H11N7	5546	Moderate		Inter Info	[31], [32], [33]
	Increased risk of ventricular arrhythmias					Drug Num: 1
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D1569		Thalidomide	C13H10N2O4	5426	Moderate		Inter Info	[7], [8], [91]
	Potentiated the pharmacological effects (Unspecific)					Drug Num: 2
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0581		Epinephrine	C9H13NO3	5816	Major		Inter Info	[13], [14], [15]
D1016		Methacholine	C8H18NO2+	1993	Major		Inter Info	[17]
Pharmacodynamic antagonistic effects
	Antagonize the effect of antidiabetic agents					Drug Num: 1
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D1801		Glucagon	C153H225N43O49S	16132283	Minor		Inter Info	[102], [103], [104]
	Antagonize the effect of antihypertensive agents					Drug Num: 5
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0101		Arbutamine	C18H23NO4	60789	Moderate		Inter Info	[42]
D0510		Dobutamine	C18H23NO3	36811	Moderate		Inter Info	[55], [15], [56]
D0517		Dopamine	C8H11NO2	681	Moderate		Inter Info	[55], [15], [56]
D1013		Metaraminol	C9H13NO2	5906	Moderate		Inter Info	[55], [15], [56]
D1153		Norepinephrine	C8H11NO3	439260	Moderate		Inter Info	[55], [15], [56]
	Antagonize the effect of bronchodilators					Drug Num: 19
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0064		Aminophylline	C16H24N10O4	9433	Major		Inter Info	[1], [2], [3]
D0103		Arformoterol	C19H24N2O4	3083544	Major		Inter Info	[4], [5], [6]
D0544		Dyphylline	C10H14N4O4	3182	Major		Inter Info	[1], [2], [3]
D0691		Formoterol	C19H24N2O4	3410	Major		Inter Info	[4], [5], [6]
D0797		Indacaterol	C24H28N2O3	6918554	Major		Inter Info	[4], [5], [6]
D0924		Levosalbutamol	C13H21NO3	123600	Major		Inter Info	[4], [5], [6]
D1171		Olodaterol	C21H26N2O5	11504295	Major		Inter Info	[4], [5], [6]
D1185		Orciprenaline	C11H17NO3	4086	Major		Inter Info	[4], [5], [6]
D1201		Oxtriphylline	C12H21N5O3	656652	Major		Inter Info	[1], [2], [3]
D1298		Pirbuterol	C12H20N2O3	4845	Major		Inter Info	[4], [5], [6]
D1374		Racepinephrine	C9H13NO3	838	Major		Inter Info	[4], [5], [6]
D1414		Ritodrine	C17H21NO3	33572	Major		Inter Info	[18]
D1438		Salbutamol	C13H21NO3	2083	Major		Inter Info	[4], [5], [6]
D1440		Salmeterol	C25H37NO4	5152	Major		Inter Info	[4], [5], [6]
D1554		Terbutaline	C12H19NO3	5403	Major		Inter Info	[4], [5], [6]
D1695		Vilanterol	C24H33Cl2NO5	10184665	Major		Inter Info	[4], [5], [6]
D0854		Isoetharine	C13H21NO3	3762	Major		Inter Info	[4], [5], [6]
D1570		Theophylline	C7H8N4O2	2153	Major		Inter Info	[1], [2], [3]
D0859		Isoprenaline	C11H17NO3	3779	Moderate		Inter Info	[76], [77], [78]
	Attenuated pharmacological effects (Unspecific)					Drug Num: 1
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D1536		Tasimelteon	C15H19NO2	10220503	Moderate		Inter Info	[90]

References
1	Lombardi TP, Bertino JS, Goldberg A, Middleton E, Slaughter RL "The effects of a beta-2 selective adrenergic agonist and a beta- nonselective antagonist on theophylline clearance." J Clin Pharmacol 27 (1987): 523-9. [PMID: 2888791]
2	Mue S, Sasaki T, Shibahara S, et alT "Influence of metoprolol on hemodynamics and respiratory function in asthmatic patients." Int J Clin Pharmacol Biopharm 17 (1979): 346-50. [PMID: 489201]
3	Upton RA "Pharmacokinetic interactions between theophylline and other medication (Part II)." Clin Pharmacokinet 20 (1991): 135-50. [PMID: 1709398]
4	Craig TJ "Drugs to be used with caution in patients with asthma." Am Fam Physician 54 (1996): 947-53.[PMID: 8784166]
5	Chafin CC, Soberman JE, Demirkan K, Self T "Beta-blockers after myocardial infarction: Do benefits ever outweigh risks in asthma?." Cardiology 92 (1999): 99-105.[PMID: 10702651]
6	Chodosh S, Tuck J, Blasucci DJ "The effects of dilevalol, metoprolol, and placebo on ventilatory function in asthmatics." J Cardiovasc Pharmacol 11 (1988): s18-24.[PMID: 2464094]
7	Cerner Multum, Inc. "Australian Product Information.".
8	Cerner Multum, Inc. "UK Summary of Product Characteristics.".
9	Product Information. Zykadia (ceritinib). Novartis Pharmaceuticals, East Hanover, NJ.
10	Strauss FG, Franklin SS, Lewin AJ, Maxwell MH "Withdrawal of antihypertensive therapy. Hypertensive crisis in renovascular hypertension." JAMA 238 (1977): 1734-6.[PMID: 578267]
11	Bailey RR, Neale TJ "Rapid clonidine withdrawal with blood pressure overshoot exaggerated by beta-blockage." Br Med J 1 (1976): 942-3.[PMID: 5169]
12	Lilja M, Jounela AJ, Juustila H, Mattila MJ "Interaction of clonidine and beta-blockers." Acta Med Scand 207 (1980): 173-6.[PMID: 6102839]
13	Spencer PS, Klein LE "Interaction of epinephrine and propranolol." J Am Acad Dermatol 14 (1986): 1093-4.[PMID: 3722489]
14	O'Grady J, Oh V, Turner P "Effects of propranolol and oxprenolol on the vasoconstrictor response to noradrenaline in the superficial hand vein in man." Eur J Clin Pharmacol 14 (1978): 83-5.[PMID: 720378]
15	Richards DA, Prichard BN, Hernandez R "Circulatory effects of noradrenaline and adrenaline before and after labetalol." Br J Clin Pharmacol 7 (1979): 371-8.[PMID: 444356]
16	Product Information. Azedra (iobenguane I-131). Progenics Pharmaceuticals, Inc., New York, NY.
17	Product Information. Provocholine (methacholine). Methapharm Inc, Brantford, ON.
18	Product Information. Yutopar (ritodrine). Astra USA, Westborough, MA.
19	Product Information. Mayzent (siponimod). Novartis Pharmaceuticals, East Hanover, NJ.
20	Packer M "Combined beta-adrenergic and calcium-entry blockage in angina pectoris." N Engl J Med 320 (1989): 709-18. [PMID: 2564164]
21	Product Information. Covera-HS (verapamil). Searle, Skokie, IL.
22	Rocha P, Guerret M, David D, Marchand X, Kahn JC "Kinetics and hemodynamic effects of intravenous nicardipine modified by previous propranolol oral treatment." Cardiovasc Drugs Ther 4 (1990): 1525-32. [PMID: 2081146]
23	Chrysant SG "Experience with terazosin administered in combination with other antihypertensive agents." Am J Med 80 (1986): 55-61. [PMID: 2872808]
24	Holtzman JL, Kaihlanen PM, Rider JA, Lewin AJ, Spindler JS, Oberlin JA "Concomitant administration of terazosin and atenolol for the treatment of essential hypertension." Arch Intern Med 148 (1988): 539-43. [PMID: 3277569]
25	Product Information. Xatral (alfuzosin). Sanofi-Synthelabo Canada Inc, Markham, ON.
26	Henry M, Kay MM, Viccellio P "Cardiogenic shock associated with calcium-channel and beta blockers: reversal with intravenous calcium chloride." Am J Emerg Med 3 (1985): 334-6. [PMID: 2860911]
27	Pouleur H, Etienne J, Van Mechelen H, et al "Effects of nicardipine or nifedipine added to propranolol in patients with coronary artery disease." Postgrad Med J 60 (1984): 23-8. [PMID: 6527976]
28	Strauss WE, Egan T, McIntyre KM, Parisi AF "Combination therapy with diltiazem and propranolol: precipitation of congestive heart failure." Clin Cardiol 8 (1985): 363-6. [PMID: 4006348]
29	Product Information. Timoptic (timolol ophthalmic). Merck &amp Co, Inc, West Point, PA.
30	Product Information. Acupress (carteolol ophthalmic). Otsuka American Pharmaceuticals Inc, Rockville, MD.
31	Dean S, Kendall MJ, Potter S, Thompson MH, Jackson DA "Nadolol in combination with indapamide and xipamide in resistant hypertensives." Eur J Clin Pharmacol 28 (1985): 29-33. [PMID: 3987783]
32	Dornhorst A, Powell SH, Pensky J "Aggravation by propranolol of hyperglycaemic effect of hydrochlorothiazide in type II diabetics without alteration of insulin secretion." Lancet 1 (1985): 123-6. [PMID: 2857210]
33	Product Information. Lozol (indapamide). Rhone-Poulenc Rorer, Collegeville, PA.
34	Product Information. Alphagan (brimonidine ophthalmic). Allergan Inc, Irvine, CA.
35	Product Information. Mirvaso (brimonidine topical). Galderma Laboratories Inc, Cranbury, NJ.
36	Walters TR "Development and use of brimonidine in treating acute and chronic elevations of intraocular pressure: a review of safety, efficacy, dose response, and dosing studies." Surv Ophthalmol 41 ( Suppl (1996): s19-26
37	Product Information. Kaletra (lopinavir-ritonavir) Abbott Pharmaceutical, Abbott Park, IL.
38	Product Information. Alecensa (alectinib). Genentech, South San Francisco, CA.
39	Leor J, Levartowsky D, Sharon C, Farfel Z "Amiodarone and beta-adrenergic blockers: an interaction with metoprolol but not with atenolol." Am Heart J 16 (1988): 206-7. [PMID: 3394625]
40	Ogunyankin KO, Singh BN "Mortality reduction by antiadrenergic modulation of arrhythmogenic substrate: Significance of combining beta blockers and amiodarone." Am J Cardiol 84 (1999): r76-82. [PMID: 10568664]
41	Boutitie F, Boissel JP, Connolly SJ, et al "Amiodarone interaction with beta-blockers - Analysis of the merged EMIAT (European Myocardial Infarct Amiodarone Trial) and CAMIAT (Canadian Amiodarone Myocardial Infarction Trial) databases." Circulation 99 (1999): 2268-75. [PMID: 10226092]
42	Product Information. GenESA (arbutamine). Gensia Inc, San Diego, CA.
43	Harrah MD, Way WL, Katzung BG "The interaction of d-tubocurarine with antiarrhythmic drugs." Anesthesiology 33 (1970): 406-10. [PMID: 5512329]
44	Loan PB, Connolly FM, Mirakhur RK, Kumar N, Farling P "Neuromuscular effects of rocuronium in patients receiving beta-adrenoreceptor blocking, calcium entry blocking and anticonvulsant drugs." Br J Anaesth 78 (1997): 90-1. [PMID: 9059213]
45	Rozen MS, Whan FM "Prolonged curarization associated with propranolol." Med J Aust 1 (1972): 467-8. [PMID: 5024418]
46	Product Information. Alunbrig (brigatinib). Ariad Pharmaceuticals Inc, Cambridge, MA.
47	Product Information. Cafergot (caffeine-ergotamine). Novartis Pharmaceuticals, East Hanover, NJ.
48	Product Information. Migranal (dihydroergotamine nasal). Novartis Pharmaceuticals, East Hanover, NJ.
49	Venter CP, Joubert PH, Buys AC "Severe peripheral ischaemia during concomitant use of beta blockers and ergot alkaloids." Br Med J 289 (1984): 288-9
50	Product Information. Xalkori (crizotinib). Pfizer U.S. Pharmaceuticals Group, New York, NY.
51	Canadian Pharmacists Association "e-CPS."
52	Watt DA "Sensitivity to propranolol after digoxin intoxication." Br Med J 2 (1968): 413-4
53	Lowenthal DT, Porter RS, Saris SD, Bies CM, Slegowski MB, Staudacher A "Clinical pharmacology, pharmacodynamics and interactions with esmolol." Am J Cardiol 56 (1985): f14-8
54	Product Information. Zebeta (bisoprolol). Lederle Laboratories, Wayne, NJ.
55	Product Information. Dobutrex (dobutamine). Lilly, Eli and Company, Indianapolis, IN.
56	Product Information. Intropin (dopamine). DuPont Pharmaceuticals, Wilmington, DE.
57	Product Information. Multaq (dronedarone). sanofi-aventis , Bridgewater, NJ.
58	Product Information. Osmovist 240 (iotrolan). Berlex Canada Inc, Lachine, QC.
59	Product Information. Visipaque (iodixanol). Nycomed Inc, Princeton, NJ.
60	Costa N "Understanding contrast media." J Infus Nurs 27 (2004): 302-12. [PMID: 15385894]
61	Product Information. Corlopam (fenoldopam). Neurex, Menlo Park, CA.
62	Product Information. Gilenya (fingolimod). Novartis Pharmaceuticals, East Hanover, NJ.
63	FDA. U.S. Food and Drug Administration "FDA Drug Safety Communication: Revised recommendations for cardiovascular monitoring and use of multiple sclerosis drug Gilenya (fingolimod).".
64	Minish T, Herd A "Symptomatic bradycardia secondary to interaction between topical timolol maleate, verapamil, and flecainide: a case report." J Emerg Med 22 (2002): 247-9. [PMID: 11932086]
65	Lewis GP, Holtzman JL "Interaction of flecainide with digoxin and propranolol." Am J Cardiol 53 (1984): b52-7
66	Holtzman JL, Kvam DC, Berry DA, et al "The pharmacodynamic and pharmacokinetic interaction of flecainide acetate with propranolol: effects on cardiac function and drug clearance." Eur J Clin Pharmacol 33 (1987): 97-9
67	Ray K, Dorman S, Watson R "Severe hyperkalaemia due to the concomitant use of salt substitutes and ACE inhibitors in hypertension: a potentially life threatening interaction." J Hum Hypertens 13 (1999): 717-20. [PMID: 10516744]
68	Product Information. Vasotec (enalapril). Merck &amp Co, Inc, West Point, PA.
69	Product Information. AK-Fluor (fluorescein). Akorn Inc, Buffalo Grove, IL.
70	EMEA. European Medicines Agency "EPARs. European Union Public Assessment Reports.".
71	Kronig MH, Roose SP, Walsh BT, Woodring S, Glassman AH "Blood pressure effects of phenelzine." J Clin Psychopharmacol 3 (1983): 307-10. [PMID: 6630590]
72	Product Information. Marplan (isocarboxazid) Roche Laboratories, Nutley, NJ.
73	Product Information. Matulane (procarbazine). Roche Laboratories, Nutley, NJ.
74	Product Information. Zanaflex (tizanidine). Acorda Therapeutics, Hawthorne, NY.
75	Jounela AJ, Lilja M "Interactions between beta-blockers and clonidine." Ann Clin Res 16 (1984): 181-2
76	Pickles H, Perucca E, Fish A, Richens A "Propranolol and sotalol as antagonists of isoproterenol-enhanced physiologic tremor." Clin Pharmacol Ther 30 (1981): 303-10
77	Ziegler MG, Chernow B, Woodson LC, Coyle J, Cruess D, Lake CR "The effect of propranolol on catecholamine clearance." Clin Pharmacol Ther 40 (1986): 116-9
78	Johnsson G, Svedmyr N, Thiringer G "Effects of intravenous propranolol and metoprolol and their interaction with isoprenaline on pulmonary function, heart rate and blood pressure in asthmatics." Eur J Clin Pharmacol 8 (1975): 175-80
79	Product Information. Corlanor (ivabradine). Amgen USA, Thousand Oaks, CA.
80	Product Information. Sandostatin (octreotide). Sandoz Pharmaceuticals Corporation, East Hanover, NJ.
81	Product Information. Somatuline Depot (lanreotide). Ipsen Inc, Milford, MA.
82	Product Information. Reyvow (lasmiditan). Lilly, Eli and Company, Indianapolis, IN.
83	Product Information. Zeposia (ozanimod). Celgene Corporation, Summit, NJ.
84	Canadian Pharmacists Association.
85	Product Information. Exelon (rivastigmine) Novartis Pharmaceuticals, East Hanover, NJ.
86	Product Information. Salagen Tablets (pilocarpine). Boehringer-Ingelheim, Ridgefield, CT.
87	Gilman AG, Rall TW, Nies AS, Taylor P, eds. "Goodman and Gilman's the Pharmacological Basis of Therapeutics. 8th ed." New York, NY: Pergamon Press Inc. (1990):.
88	Product Information. Sufenta (sufentanil). Janssen Pharmaceutica, Titusville, NJ.
89	Thomson IR, MacAdams CL, Hudson RJ, Rosenbloom M "Drug interactions with sufentanil: hemodynamic effects of premedication and muscle relaxants." Anesthesiology 76 (1992): 922-9
90	Product Information. Hetlioz (tasimelteon). Vanda Pharmaceuticals Inc, Rockville, MD.
91	Product Information. Thalomid (thalidomide). Celgene Corporation, Warren, NJ.
92	Rubino M, Jackson E "Severe paranoia with concomitant tocainide and propranolol therapy." Clin Pharm 1 (1982): 177-9
93	Ikram H "Hemodynamic and electrophysiologic interactions between antiarrhythmic drugs and beta blockers, with special reference to tocainide." Am Heart J 100 (1980): 1076-80
94	Roden DM, Woosley RL "Tocainide." N Engl J Med 315 (1986): 41-5
95	Bonde J, Bodtker S, Angelo HR, Svedsen TL, Kampmann JP "Atenolol inhibits the elimination of disopyramide." Eur J Clin Pharmacol 28 (1985): 41-3. [PMID: 3987784]
96	Bonde J, Pedersen LE, Angelo HR, Trap-Jensen J, Svedsen TL, Kampmann JP "Haemodynamic effects and kinetics of concomitant intravenous disopyramide and atenolol in patients with ischaemic heart disease." Eur J Clin Pharmacol 30 (1986): 161-6. [PMID: 3709640]
97	Cathcart-Rake WF, Coker JE, Atkins FL, et al "The effect of concurrent oral administration of propranolol and disopyramide on cardiac function in healthy men." Circulation 61 (1980): 938-45. [PMID: 7363436]
98	Product Information. ProAmatine (midodrine). Roberts Pharmaceutical Corporation, Eatontown, NJ.
99	Cass E, Kadar D, Stein HA "Hazards of phenylephrine topical medication in persons taking propranolol." Can Med Assoc J 120 (1979): 1261-2. [PMID: 221086]
100	Myers MG, Iazzetta JJ "Intranasally administered phenylephrine and blood pressure." Can Med Assoc J 127 (1982): 365-6. [PMID: 7104913]
101	Product Information. Brilinta (ticagrelor). Astra-Zeneca Pharmaceuticals, Wilmington, DE.
102	Smith RC, Wilkinson J, Hull RL "Glucagon for propranolol overdose." JAMA 254 (1985): 2412. [PMID: 4046162]
103	Smith RC, Wilkinson DO, Hull RL "Glucagon for propranolol overdose." JAMA 254 (1985): 2412. [PMID: 4046162]
104	Mills GA, Horn JR "B-blockers and glucose control." Drug Intell Clin Pharm 19 (1985): 246-51. [PMID: 2861072]

Details of Drug

Details of Drug

Cite MecDDI

About MecDDI

Correspondence